volume 28, issue 2, P297-301 2012
DOI: 10.3233/jad-2011-111118
View full text
|
Sign up to set email alerts
|
Share

Abstract: This work describes a novel mechanism of neuroprotection by simvastatin: the modulation of seladin-1, an enzyme involved in Alzheimer's disease. Genomic and proteomic studies in human neuronal cells showed seladin-1 production to be increased in a dose- and time-dependent manner by simvastatin. This was confirmed in mice by immunohistochemical and qRT-PCR studies.

Search citation statements

Order By: Relevance

Citation Types

0
10
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals